C12N 2501/2301
Interleukin-1
Official title: Interleukin-1 (IL-1)
C12N2501/2301 (Interleukin-1) appears on 100 US grants and 236 published applications in this corpus.
Search patents in C12N- Granted patents
- 100
- Published applications
- 236
- Assignees
- 170
- Inventors
- 521
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 3 |
| 2012 | 1 | 1 |
| 2013 | 3 | 6 |
| 2014 | 1 | 5 |
| 2015 | 2 | 14 |
| 2016 | 3 | 12 |
| 2017 | 8 | 8 |
| 2018 | 9 | 10 |
| 2019 | 8 | 17 |
| 2020 | 5 | 22 |
| 2021 | 10 | 26 |
| 2022 | 3 | 21 |
| 2023 | 7 | 23 |
| 2024 | 18 | 27 |
| 2025 | 8 | 21 |
| 2026 | 5 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- B-cell cultivation method4 Aug 2026US 12,698,474 B2Hoffmann-La Roche Inc.
- Biocompatible conditioned cell medium compositions and uses thereof16 Jun 2026US 12,655,384 B2Cellum Biomedical, Inc.
- Mammalian cell population and medicaments for cell therapies in humans and improved cell cultivation methods12 May 2026US 12,624,341 B2SCARCELL Therapeutics
- Method for increasing dendritic cell migration ability, and use thereof14 Apr 2026US 12,600,946 B2Cha University Industry-Academic Cooperation Foundation
- Compositions and methods for treating HIV infection and reversing HIV latency6 Jan 2026US 12,514,921 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Metabolically enhanced vd1 t cells and uses thereof8 Oct 2026US 2026/0308518 A1
- Single b-cell cultivation method24 Sep 2026US 2026/0285949 A1Hoffmann-La Roche Inc.
- Methods for the production of dendritic cells by modulating retinoid signaling6 Aug 2026US 2026/0226411 A1FUJIFILM Holdings America Corporation
- Method for producing car-t cells23 Jul 2026US 2026/0209704 A1Takeda Pharmaceutical Company Limited
- Two-dimensional processes for the expansion of tumor infiltrating lymphocytes and therapies therefrom9 Jul 2026US 2026/0193606 A1Iovance Biotherapeutics, Inc.
Most cited
By later US patents
- Connective tissue regeneration using human mesenchymal stem cell preparations470US 5,811,094 AOsiris Therapeutics, Inc. · 1998
- Lineage-directed induction of human mesenchymal stem cell differentiation264US 5,736,396 ACase Western Reserve University · 1998
- Lineage-directed induction of human mesenchymal stem cell differentiation212US 5,942,225 ACase Western Reserve University · 1999
- Monoclonal antibodies for human mesenchymal stem cells178US 5,837,539 AOsiris Therapeutics, Inc. · 1998
- Monoclonal antibodies for human mesenchymal stem cells178US 6,087,113 ACase Western Reserve University · 2000